Partington et al. reported that carcinoembryonic antigen (CEA), which is an oncofetal glycoprotein, is associated with atypical meningioma without secretory features, and a decline in CEA levels is associated with effective treatment of the symptomatic tumor [10]. This evidence concerns the gene CEACAM5 and meningioma.